An observational study in Pancreas; Fistula, sponsored by Chang Gung Memorial Hospital. Completed. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2020-06-26.
Sponsored by Chang Gung Memorial Hospital · Observational
This study investigated the impact of highest drain fluid amylase (DFA) level on postoperative pancreatic fistula (POPF) severity and outcomes of patients undergoing pancreaticoduodenectomy (PD) with POPF. Patient demographics of biochemical POPF and clinically relevant POPF (CR-POPF) were compared. Predictive factors were assessed using binary logistic regression. Receiver operating characteristic curve analysis was performed to determine the optimal cutoff value of highest DFA (beyond 3 days post-PD). The investigators compared length of hospital stay, surgical mortality rates, and need for postoperative interventions by highest DFA level.
125 studies on the registry are indexed under Pancreatic Fistula; 27 are open to participants now.
This study's enrollment of 600 is above the median of 173 across 49 observational studies indexed under Pancreatic Fistula.
Browse Pancreatic Fistula studies →Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.
Counted across the registry records on this site, refreshed daily.
underwent PD in Chang Gung Memorial Hospital at Linkou
Exclusion Criteria:
postoperative pancreatic fistula
fluid output of any measureable volume via an operatively placed drain with amylase activity greater than 3 times the upper normal serum value
Time frame: through study completion, an average of 2 month
postoperative interventions
transarterial embolization, image-guided second drainage, and reoperation
Time frame: through study completion, an average of 2 month
length of hospital stay
Time frame: through study completion, an average of 2 month
30-day mortality rates
Time frame: 30 day
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chang Gung Memorial Hospital